Suppr超能文献

甲状腺功能亢进症手术治疗后对促甲状腺激素释放激素试验和三碘甲状腺原氨酸抑制试验反应性的变化(作者译)

[Changes in responsivity to TRH test and T3-suppression test after surgical treatment of hyperthyroidism (author's transl)].

作者信息

Tamai H, Fujino R, Shizume K, Kuma K, Suematsu H

出版信息

Nihon Naibunpi Gakkai Zasshi. 1975 Dec 20;51(12):985-96. doi: 10.1507/endocrine1927.51.12_985.

Abstract

TRH test and T3 suppression test were performed on patients with Graves' disease who underwent subtotal thyroidectomy after treatment with antithyroid drugs for 2.5 approximately 5 months. On 43 or the patients, TRH test was performed before, 1 week after and 1 approximately 2 months after surgery and T3 suppression test was also performed in 1 approximately 2 months post-operative period. For other 3 groups of the patients TRH test was performed at 2 approximatley 6 months, 6 approximately 12 months, 12 approximately 24 months and 24 approximately 41 months after surgery, and T3 suppression test was also performed just after each TRH test. As to TRH test, the response was defined as positive when basal TSH value was less than 2.0 muU/ml and peak value was more than 6.2 muU/ml or the difference between basal TSH and peak TSH value was over 5 muU/ml following TRH (500 mug) injection. T3 suppression test was perfomed by measuring the 24-hr thyroidal uptake of radioiodine after daily administration of 75 mug of T3 for 8 days. The response was defined as positive when the value for 24-hr uptake after T3 administration was less than half of the control value. The results were as follows; (1) In 11 of 43 patients, response to TRH test already changed to positive 1 week after operation and in 21 of 43 patients TRH test changes to positive 1 approximately 2 months after operation. (2) In general, response to TRH test changed to positive earlier than response to T3 suppression test. (3) T3 suppression test in 1 approximately 2 months after operation was useful to evaluate prognosis. (4) A half of the positive respondents to TRH test showed exaggerated response. (5) Basal TSH value of positive respondents to TRH test was 9.27 +/- 1.81 muU/ml (mean +/- SE) which exceeded the normal range. (6) Some patients showed negative response to conventional T3 suppression test despite of their high basal TSH value. This might be due to the insufficient dose of T3 to suppress TSH. (7) Concerning patients whose serum T3-RU, T4, T3 and TSH were within normal limit after subtotal thyroidectomy, 80% of them showed correspondance in the results of TRH test and T3 suppression test.

摘要

对接受抗甲状腺药物治疗约2.5至5个月后行甲状腺次全切除术的格雷夫斯病患者进行了促甲状腺激素释放激素(TRH)试验和T3抑制试验。43例患者在手术前、术后1周以及术后1至2个月进行了TRH试验,并且在术后1至2个月期间也进行了T3抑制试验。对于其他3组患者,在术后2至6个月、6至12个月、12至24个月以及24至41个月进行了TRH试验,并且在每次TRH试验后也进行了T3抑制试验。关于TRH试验,当静脉注射TRH(500μg)后基础促甲状腺激素(TSH)值低于2.0μU/ml且峰值高于6.2μU/ml,或者基础TSH与峰值TSH值之差超过5μU/ml时,反应被定义为阳性。T3抑制试验是在每天给予75μg T3共8天后,测量24小时甲状腺对放射性碘的摄取来进行的。当给予T3后24小时摄取值低于对照值的一半时,反应被定义为阳性。结果如下:(1)43例患者中有11例在术后1周TRH试验反应已转为阳性,43例患者中有21例在术后1至2个月TRH试验转为阳性。(2)一般来说,TRH试验反应比T3抑制试验反应更早转为阳性。(3)术后1至2个月的T3抑制试验有助于评估预后。(4)TRH试验阳性反应者中有一半表现出过度反应。(5)TRH试验阳性反应者的基础TSH值为9.27±1.81μU/ml(平均值±标准误),超过正常范围。(6)一些患者尽管基础TSH值较高,但对传统T3抑制试验表现出阴性反应。这可能是由于T3抑制TSH的剂量不足。(7)关于甲状腺次全切除术后血清总三碘甲状腺原氨酸摄取率(T3-RU)、甲状腺素(T4)、三碘甲状腺原氨酸(T3)和TSH在正常范围内的患者,其中80%在TRH试验和T3抑制试验结果上表现出一致性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验